BackFresh Tracks Therapeutics Overview

Fresh Tracks Therapeutics Gross Profit

Gross Profit analysis for FRTX.

Quarterly Gross Profit

N/A

As of Dec 31, 2023

Annual Gross Profit (TTM)

$5.46M
21.35% YoY

Trailing 12 months ending Dec 31, 2023

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)